✦ LIBER ✦

Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation

✍ Scribed by T. Kuittinen; E. Jantunen; E. Vanninen; H. Mussalo; O. Vuolteenaho; M. Ala-Kopsala; T. Nousiainen; J. Hartikainen

Book ID: 114794043
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 139 KB
Volume: 77
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2006.00687.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Very acute cardiac toxicity during BEAC

Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation

✍ Ala-Kopsala, M; Nousiainen, T; Jantunen, E; Hartikainen, J; Kuittinen, T; Husso- 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 129 KB

BEAC or BEAM high-dose chemotherapy foll

BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin’s lymphoma patients: comparative analysis of efficacy and toxicity

✍ Jae-Cheol Jo; Byung Wook Kang; Geundoo Jang; Sun Jin Sym; Sung Sook Lee; Ja Eun 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 144 KB

High Dose Therapy and Autologous Stem Ce

High Dose Therapy and Autologous Stem Cell Transplantation Results in Good Outcomes and Acceptable Toxicities in Elderly Patients with Non-Hodgkin's Lymphoma

✍ Tamari, Roni; Dahi, Parastoo; Devlin, Sean; Goldberg, Jenna; Paul, Paul Hamlin; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy

✍ Arturo Molina; Amrita Y. Krishnan; Auayporn Nademanee; Rachel Zabner; Irena Snie 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

Effective purging of autologous hematopo

Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma

✍ Iain J Webb; Jonathan W Friedberg; John G Gribben; David C Fisher; Thomas Spitze 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Long Term Outcomes of Autologous Hematop

Long Term Outcomes of Autologous Hematopoietic Cell Transplant (AHCT) Following Thiotepa-Based High-Dose Therapy (HDT) in Patients with Non-Hodgkin Lymphoma (NHL)

✍ Shah, Nilay A.; Rauenzahn, Sherri; Wen, Sijin; Craig, Michael; Kanate, Abraham S 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 50 KB